Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001662426-25-000005

Director acquired 1,334 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Morrison Scott W Director 2025-09-15 Option exercise +1,334 4,684 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Morrison Scott W Director 2025-09-15 Option exercise · Restricted Stock Units −1,334 0 D: show line 2 in the form
Loading xslF345X05/wk-form4_1758053184.xml…